Gland Pharma fundamental analysis
GLAND
1851
1.80 (0.10%)Last updated on 6 Feb, 2026 | 15:53 IST
BUYSELL
The current prices are delayed, login to your account for live prices
Login Gland Pharma Fundamentals
P/E Ratio
36.02
P/B Ratio
3.11
Div. Yield
0.97
Sector P/E
63.34
Sector P/B
1.32
Sec. Div. Yield
0.58
Gland Pharma Fundamentals is currently trading with a P/E Ratio of 36.02, compared to the sector average of 63.34. Its P/B Ratio stands at 3.11, while the sector’s is 1.32. In terms of returns, the stock offers a Dividend Yield of 0.97%, which is than the sector’s 0.58%.
Gland Pharma Score Card
Price
Attractive
Growth
Moderate
Quality
Good
Management
Good
On its scorecard, Gland Pharma reflects: Price – Attractive, Growth – Moderate, Quality – Good, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.
